Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 36, n° 6
pages 956-958 (juin 1997)
Doi : 10.1016/S0190-9622(97)80280-0
Therapy

5-Fluorouracil iontophoretic therapy for Bowen's disease
 

Mark L. Welch a : MAJ, William J. Grabski b : LTC, Martha L. McCollough b : LTC, Henry G. Skelton c : CAPT, Kathleen J. Smith d : COL, Padman A. Menon d : CDR, Lawrence L. Anderson b : LTC
a Dermatology Service, Walter Reed Army Medical Center, Washington, Washington, D.C., Ft. Sam Houston, Texas, and Bethesda, Maryland, USA 
b Dermatology Service, Brooke Army Medical Center, Ft. Sam Houstonb, Washington, D.C., Ft. Sam Houston, Texas, and Bethesda, Maryland, USA 
c Dermatology Department, Armed Forces Institute of Pathology, Washington, Washington, D.C., Ft. Sam Houston, Texas, and Bethesda, Maryland, USA 
d Dermatology Service, Bethesda Naval Medical Center, Washington, D.C., Ft. Sam Houston, Texas, and Bethesda, Maryland, USA 

Abstract
Background:

Topical 5-fluorouracil (5-FU) is an accepted therapy for Bowen's disease. Recurrences with this method have been attributed to deep follicular involvement and poor patient compliance because of the prolonged treatment time required.

Objective:

We sought to determine whether iontophoresis of 5-FU is an effective therapy for Bowen's disease.

Methods:

Twenty-six patients with biopsy-proven Bowen's disease received eight 5-FU iontophoretic treatments in 4 weeks. Local excision was done 3 months after the last treatment. The specimens were step-sectioned and evaluated for any histologic evidence of bowenoid changes.

Results:

Only 1 of 26 patients showed histologic evidence of Bowen's disease 3 months after treatment.

Conclusion:

5-FU iontophoresis appears to be a safe, effective, and well-tolerated therapy for Bowen's disease.

The full text of this article is available in PDF format.

Top of the page

© 1997  Published by Elsevier Masson SAS.